Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 813-819

  Brugière, Olivier ^a   Thabut, G ^a   Mal, H ^a   Marceau, A ^a   Dauriat, G ^a   Marrash Chahla, R ^a   Castier, Y ^a   Leseche G ^a   Colombat, M ^a   Fournier, M ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Bronchiolitis obliterans syndrome; Exhaled nitric oxide; Lung transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; EMPHYSEMA; EXHALATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; RECIPIENT;

ADULT; AGED; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHIOLITIS OBLITERANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; SENSITIVITY AND SPECIFICITY;

EID: 20844462377     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00057004     Document Type: Article

References (21)

1. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 1995; 60: 1341-1346.
2. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998; 17: 1255-1263.
3. Nathan SD, Ross DJ, Belman MJ, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995; 107: 967-972.
4. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
5. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27: 389-393.
6. Gabbay E, Haydn Walters E, Orsida B. et al. In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS. Am J Respir Crit Care Med 1999; 160: 2093-2099.
7. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153: 1773-1780.
8. Kharitonov SA, Yates D. Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
9. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995; 8: 295-297.
10. Paredi P, Kharitonov SA, Loukides S, Pantelidis P, du Bois RM, Barnes PJ. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999; 115: 1352-1356.
11. Moodley YP, Lalloo UG. Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease. Chest 2001; 119: 1449-1454.
12. Fisher AJ, Gabbay E, Small T, Doig S, Dark JH, Corris PA. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998; 53: 454-458.
13. Gabbay E, Walters EH, Orsida B, et al. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthetase. Am J Respir Crit Care Med 2000; 162: 2182-2187.
14. Verleden GM, Dupont LJ, Delcroix M, et al. Exhaled nitric oxide after lung transplantation: impact of the native lung. Eur Respir J 2003; 21: 429-432.
15. Verleden GM, Dupont LJ, Delcroix M, et al. Accuracy of exhaled nitric oxide (FENO) for the diagnosis of chronic rejection (CR) after lung transplantation (LTX). J Heart Lung Transplant 2003; 22: Suppl. 1S, S182.
16. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1-15.
17. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
18. Silkoff P, McLean P, Slusky A, et al. Effect of pressure and flow on measurement of exhaled and nasal nitric oxide. Am J Respir Crit Care Med 1997; 155: 260-267.
19. Kharitonov SA, Barnes PJ. There is no nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath-hold. Thorax 1997; 52: 540-544.
20. Verleden GM, Dupont L, Lamont J, et al. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection? J Heart Lung Transplant 1998; 17: 231-232.
21. Silkoff PE, Caramori M, Tremblay L, et al. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute lung rejection. Am J Respir Crit Care Med 1998; 157: 1822-1828.